Deprescribing psychotropic medicines for behaviours that challenge in people with intellectual disabilities: a systematic review.

ABSTRACT:

Background

Clear evidence of overprescribing of psychotropic medicines to manage behaviours that challenges in people with intellectual disabilities has led to national programmes within the U.K. such as NHS England's STOMP to address this. The focus of the intervention in our review was deprescribing of psychotropic medicines in children and adults with intellectual disabilities. Mental health symptomatology and quality of life were main outcomes.

Methods

We reviewed the evidence using databases Medline, Embase, PsycINFO, Web of Science, CINAHL and Open Grey with an initial cut-off date of 22nd August 2020 and an update on 14th March 2022. The first reviewer (DA) extracted data using a bespoke form and appraised study quality using CASP and Murad tools. The second reviewer

SUBMITTER: Adams D 

PROVIDER: S-EPMC10044393 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature